关于盟科
公司简介
管理团队
愿景与使命
发展历程
联系我们
科学研究
抗生素耐药性
肾病靶向治疗
盟科研发模式
发表文献
研发管线
新闻中心
新闻发布
投资者关系
公司治理
临时公告
定期报告
投资者服务
股票信息
加入我们
联系我们
En
科学研究
以良药求良效。
首页
发表文献
抗生素耐药性
肾病靶向治疗
盟科研发模式
发表文献
Contezolid can replace linezolid in a novel combination with bedaquiline and pretomanid in a murine model of tuberculosis
Antimicrobial Agents and Chemotherapy / 2024
View Publication
Preclinical toxicity evaluation of novel antibacterial contezolid acefosamil in rats and dogs
J Appl Toxicol / 2024
View Publication
Dose adjustment not required for contezolid in patients with moderate hepatic impairment based on pharmacokinetic/pharmacodynamic analysis
Sec. Pharmacology of Infectious Diseases / 2023
View Publication
In vivo pharmacodynamic study of contezolid acefosamil, a prodrug of contezolid for oral and intravenous administration
Journal of Antimicrobial Chemotherapy / 2023
View Publication
A phase I study of the safety, tolerability, and pharmacokinetics of contezolid acefosamil after intravenous and oral administration in healthy Chinese subjects
Antimicrobial Agents and Chemotherapy / 2023
View Publication
A Novel Leucyl-tRNA Synthetase Inhibitor, MRX-6038, Expresses Anti-Mycobacterium abscessus Activity In Vitro and In Vivo
Antimicrobial Agents and Chemotherapy / 2022
View Publication
Discovery of Antibacterial Contezolid Acefosamil: Innovative O-Acyl Phosphoramidate Prodrug for IV and Oral Therapies
ACS Med. Chem. Lett. / 2022
View Publication
Clinical Pharmacology and Utility of Contezolid in Chinese Patients with Complicated Skin and Soft-Tissue Infections
Antimicrobial Agents and Chemotherapy / 2022
View Publication
A Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections
Journal of Antimicrobial Chemotherapy / 2022
View Publication
A Novel Oxazolidinone, Contezolid (MRX-I), Expresses Anti-Mycobacterium abscessus Activity In Vitro
Antimicrobial Agents and Chemotherapy / 2021
View Publication
Pharmacokinetics and Disposition of Contezolid in Humans: Resolution of a Disproportionate Human Metabolite for Clinical Development
Antimicrobial Agents and Chemotherapy / 2021
View Publication
Nonclinical Evaluation of Antibacterial Oxazolidinones Contezolid and Contezolid Acefosamil with Low Serotonergic Neurotoxicity
Chem Res Toxicol / 2021
View Publication
1
2
3
>
关闭